Apomine, an inhibitor of HMG-CoA-reductase, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of myeloma in vivo.
Apomine, a novel 1,1 bisphosphonate ester, increases the rate of degradation of HMG-CoA reductase, inhibiting the mevalonate pathway and thereby blocking cholesterol biosynthesis. We have investigated whether Apomine can induce myeloma cell apoptosis in vitro and modulate myeloma disease in vivo. Ap...
Những tác giả chính: | Edwards, C, Mueller, G, Roelofs, A, Chantry, A, Perry, M, Russell, R, Van Camp, B, Guyon-Gellin, Y, Niesor, E, Bentzen, C, Vanderkerken, K, Croucher, P |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
2007
|
Những quyển sách tương tự
-
Apomine, an inhibitor of HMG-COA-reductase, does not act by inhibiting protein prenylation in human myeloma cells in vitro
Bằng: Roelofs, A, et al.
Được phát hành: (2005) -
APOMINE (TM), a novel inhibitor of the meyalonate/isoprenoid pathway, promotes apoptosis of myeloma cells in vitro and is associated with a modulation of the myeloma disease in vivo.
Bằng: Croucher, P, et al.
Được phát hành: (2002) -
Apomine enhances the antitumor effects of lovastatin on myeloma cells by down-regulating 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
Bằng: Roelofs, A, et al.
Được phát hành: (2007) -
Novel insights into the anti-tumour mechanism of action of apomine and its synergistic interaction with lovastatin in myeloma cells in vitro
Bằng: Roelofs, A, et al.
Được phát hành: (2006) -
Bisphosphonates and osteoprotegerin as inhibitors of myeloma bone disease.
Bằng: Croucher, P, et al.
Được phát hành: (2003)